Hover
Uvazest contains Dienogest, which decreases Estrogen level by acting both on the peripheral and central pathway of Estrogen production with Anti-inflammatory, anti-proliferative and Anti-angiogenic properties. Endorsed by multiple gynaecology guidelines which makes it one of the trusted treatment option among medical fraternity. Uvazest ensures 33% spontaneous pregnancy rate in previously infertile patients with Endometriosis.
Indication
- In pelvic pain associated with Endometriosis
- Secondary dysmenorrhea
- Ovarian Chocolate Cyst
- Adenomyosis Pre & Post-operative treatment and Extra-genital Endometriosis
Composition
Each Tablet Contains 2mg Dienogest.
Direction of use
Dosage: One tablet once daily minimum for 6 months and can be taken any day of the cycle or as advised by your doctor.
